David T Nash

Summary

Publications

  1. pmc Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utility
    David T Nash
    Syracuse Preventive Cardiology, Syracuse, New York, USA
    Integr Blood Press Control 2:39-54. 2009
  2. ncbi request reprint Cardiovascular disease risk factors and cognitive impairment
    David T Nash
    Upstate Medical University, Syracuse Preventive Cardiology, Syracuse, New York, USA
    Am J Cardiol 97:1262-5. 2006
  3. ncbi request reprint The clinical implications and management of concomitant hypertension and dyslipidemia
    David T Nash
    State University of New York at Syracuse, Upstate Medical Center, USA
    Postgrad Med 119:37-45. 2006
  4. ncbi request reprint Use of vascular ultrasound in clinical trials to evaluate new cardiovascular therapies
    David T Nash
    Upstate Medical University, Syracuse Preventive Cardiology, Syracuse, NY, USA
    J Natl Med Assoc 100:222-9. 2008
  5. pmc Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins
    David T Nash
    Syracuse Preventive Cardiology, State University of New York Health Sciences Center, Syracuse, NY 13202, USA
    J Natl Med Assoc 97:1600-7. 2005
  6. ncbi request reprint The case for medical treatment in chronic stable coronary artery disease
    David T Nash
    Syracuse Preventive Cardiology, and Department of Medicine, State University of New York at Syracuse, Health Sciences Center, 600 E Genesee Street, Presidential Plaza Suite 204, Syracuse, NY 13202, USA
    Arch Intern Med 165:2587-9, discussion 2593-4. 2005
  7. ncbi request reprint Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide diuretics
    David T Nash
    State University of New York Upstate Medical University, Syracuse Preventive Cardiology Center, Syracuse, NY 13202, USA
    South Med J 100:386-92. 2007
  8. ncbi request reprint Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies
    David T Nash
    Upstate Medical University College of Medicine, Syracuse, NY 13202, USA
    Curr Med Res Opin 24:2617-26. 2008
  9. doi request reprint Ranolazine for chronic stable angina
    David T Nash
    Syracuse Preventive Cardiology, Syracuse, NY 13202, USA
    Lancet 372:1335-41. 2008
  10. doi request reprint Cardiovascular risk factors and dementia
    Howard Fillit
    Institute for the Study of Aging and the Alzheimer s Drug Discovery Foundation, New York, New York 10019, USA
    Am J Geriatr Pharmacother 6:100-18. 2008

Detail Information

Publications21

  1. pmc Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utility
    David T Nash
    Syracuse Preventive Cardiology, Syracuse, New York, USA
    Integr Blood Press Control 2:39-54. 2009
    ....
  2. ncbi request reprint Cardiovascular disease risk factors and cognitive impairment
    David T Nash
    Upstate Medical University, Syracuse Preventive Cardiology, Syracuse, New York, USA
    Am J Cardiol 97:1262-5. 2006
    ..Antioxidants, fatty acids, and micronutrients may have a role, and diets rich in fruits and vegetables and other dietary approaches may improve the outlook for patients considered at risk for cognitive impairment...
  3. ncbi request reprint The clinical implications and management of concomitant hypertension and dyslipidemia
    David T Nash
    State University of New York at Syracuse, Upstate Medical Center, USA
    Postgrad Med 119:37-45. 2006
    ..The authors also discuss important new findings documenting the need for, and benefits of, a more integrated approach to treating this dangerous duo...
  4. ncbi request reprint Use of vascular ultrasound in clinical trials to evaluate new cardiovascular therapies
    David T Nash
    Upstate Medical University, Syracuse Preventive Cardiology, Syracuse, NY, USA
    J Natl Med Assoc 100:222-9. 2008
    ..Both IVUS and CIMT are being widely deployed in trials of new and existing CV therapies to assess their impact on slowing the progression of atherosclerosis, and their use in this regard is the subject of this review...
  5. pmc Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins
    David T Nash
    Syracuse Preventive Cardiology, State University of New York Health Sciences Center, Syracuse, NY 13202, USA
    J Natl Med Assoc 97:1600-7. 2005
    ..In the future, assessment of CRP levels may contribute importantly to clinical decision-making in reducing cardiovascular risk...
  6. ncbi request reprint The case for medical treatment in chronic stable coronary artery disease
    David T Nash
    Syracuse Preventive Cardiology, and Department of Medicine, State University of New York at Syracuse, Health Sciences Center, 600 E Genesee Street, Presidential Plaza Suite 204, Syracuse, NY 13202, USA
    Arch Intern Med 165:2587-9, discussion 2593-4. 2005
  7. ncbi request reprint Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide diuretics
    David T Nash
    State University of New York Upstate Medical University, Syracuse Preventive Cardiology Center, Syracuse, NY 13202, USA
    South Med J 100:386-92. 2007
    ..Complementary combinations of antihypertensive agents provide an efficient and effective approach to hypertension management...
  8. ncbi request reprint Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies
    David T Nash
    Upstate Medical University College of Medicine, Syracuse, NY 13202, USA
    Curr Med Res Opin 24:2617-26. 2008
    ..Most patients with hypertension will require combination therapy to achieve blood pressure (BP) goals, especially the elderly, obese, or those with stage 2 hypertension...
  9. doi request reprint Ranolazine for chronic stable angina
    David T Nash
    Syracuse Preventive Cardiology, Syracuse, NY 13202, USA
    Lancet 372:1335-41. 2008
    ..Ranolazine seems to be a safe addition to current traditional drugs for chronic stable angina, especially in aggressive multidrug regimens...
  10. doi request reprint Cardiovascular risk factors and dementia
    Howard Fillit
    Institute for the Study of Aging and the Alzheimer s Drug Discovery Foundation, New York, New York 10019, USA
    Am J Geriatr Pharmacother 6:100-18. 2008
    ..Evidence is accumulating to suggest that cardiovascular disease (CVD) risk factors may be instrumental in the development of dementia...
  11. ncbi request reprint Systolic hypertension
    David T Nash
    SUNY Upstate Medical University, Syracuse Preventive Cardiology Center, Syracuse, NY, USA
    Geriatrics 61:22-8. 2006
    ..In addition to blood pressure-lowering efficacy, the combination of these two classes of metabolically neutral agents may offer benefit in terms of tolerability and cognitive function...
  12. ncbi request reprint Statins. Evidence of effectiveness in older patients
    David T Nash
    Upstate Medical University, State University of New York, Syracuse, USA
    Geriatrics 58:35-6, 39-42. 2003
    ..Despite these benefits, older adults are currently undertreated for this highly treatable cardiovascular risk factor...
  13. ncbi request reprint Nuts as part of a healthy cardiovascular diet
    Stephen D Nash
    Department of Medicine, SUNY Upstate Medical University, 6141 University Hospital, 750 E Adams Street, Syracuse, NY 13210, USA
    Curr Atheroscler Rep 10:529-35. 2008
    ..Incorporating nuts into the diets of more people may lead to a variety of cardiovascular benefits...
  14. ncbi request reprint Cardiovascular risk beyond LDL-C levels. Other lipids are performers in cholesterol story
    David T Nash
    State University of New York Upstate Medical University College of Medicine, Syracuse, USA
    Postgrad Med 116:11-5. 2004
    ..He emphasizes that although studies have expanded the understanding of this disease, the knowledge needs to be put to use more consistently in clinical practice in order to provide optimal patient care...
  15. doi request reprint Translating current knowledge into dementia prevention
    Gustavo C Roman
    Alzheimer and Dementia Center, Methodist Neurological Institute, Houston, TX 77030, USA
    Alzheimer Dis Assoc Disord 26:295-9. 2012
    ....
  16. ncbi request reprint Keeping an eye on cardiovascular risk. A practical, case-study approach to assessment in office practice
    David T Nash
    American Heart Association, State University of New York Health Science Center, Syracuse College of Medicine, NY, USA
    Postgrad Med 111:107-10, 113-4, 119-20. 2002
    ....
  17. ncbi request reprint Insulin resistance, ADMA levels, and cardiovascular disease
    David T Nash
    JAMA 287:1451-2. 2002
  18. ncbi request reprint A statin for a patient with hyperlipidemia and hepatitis C?
    David T Nash
    State University of New York, Health Science Center, Syracuse College of Medicine, USA
    Postgrad Med 115:86. 2004
  19. ncbi request reprint Outcomes of medical vs invasive therapy for elderly patients with angina
    David T Nash
    JAMA 289:2794; author reply 2794. 2003
  20. ncbi request reprint Need for a moratorium on percutaneous transluminal coronary angioplasty in stable coronary artery disease
    David T Nash
    Am J Cardiol 89:567-70. 2002
  21. ncbi request reprint Invasive and medical therapy for coronary artery disease
    David T Nash
    Lancet 359:354-5. 2002